Shashikant Kulkarni - Apr 1, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Scientific Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Stock symbol: NEO
Transactions as of: Apr 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/4/2023, 05:04 PM
Previous filing: Aug 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-3.76K	-4.35%	$0.00	82.7K	Apr 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						133K	Apr 1, 2023	Common Stock	133K	$12.15	Direct	F2
holding	NEO	Stock Option (Right to Buy)						51.7K	Apr 1, 2023	Common Stock	51.7K	$10.12	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the April 1, 2023 vesting of restricted stock.
F2	On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3	On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.